Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2015
Source ID
10.1016/j.neuropharm.2015.07.010

Entities

People

  • Jie Wen
  • Mikiei Tanaka
  • Rachel Ribeiro
  • Yumin Zhang

Organizations

  • National Multiple Sclerosis Society
  • Uniformed Services University of the Health Sciences